Beyond ctDNA: Towards the Integration of Multi-omics & Multimodal AI in Liquid Biopsy Assays

A NEW FRONTIERS SEMINAR | 12.05.24

This seminar brought together a diverse group of stakeholders, including academic researchers, clinicians, medical device and pharmaceutical companies, and not-for-profit organizations, to explore advancements in multi-omics and AI-driven approaches in liquid biopsy.

Be a part of the Discussion

Watch the entire seminar below.

View the Presentations

Read the White Paper

This high-level summary of the New Frontiers Seminar discussions can serve as a roadmap for BLOODPAC’s potential contributions to the field. It aims to highlight opportunities for collaboration, research, and infrastructure development that can accelerate progress in this critical area. Additionally, this summary offers insights and key questions for other organizations working at the intersection of multi-omics, AI, and liquid biopsy technology.